New McKinsey research reveals a significant AI adoption gap. While 88% of organizations use AI, nearly two-thirds haven't scaled it beyond pilots, meaning they are not behind their peers. This explains why only 39% report enterprise-level EBIT impact. True high-performers succeed by fundamentally redesigning workflows, not just experimenting.

Companies that experiment endlessly with AI but fail to operationalize it face the biggest risk of falling behind. The danger lies not in ignoring AI, but in lacking the change management and workflow redesign needed to move from small-scale tests to full integration.

Large enterprises navigate a critical paradox with new technology like AI. Moving too slowly cedes the market and leads to irrelevance. However, moving too quickly without clear direction or a focus on feasibility results in wasting millions of dollars on failed initiatives.

Many firms are stuck in "pilot purgatory," launching numerous small, siloed AI tests. While individually successful, these experiments fail to integrate into the broader business system, creating an illusion of progress without delivering strategic, enterprise-level value.

Pharma's primary AI challenge is not a lack of experimentation but a failure to execute, scale, and justify ROI. Launching additional pilots only accelerates the activity that keeps companies stuck, compounding the problem instead of solving it.

The rapid evolution of AI means a 'wait and see' approach is no longer viable for large enterprises. Companies that delay adoption while waiting for the technology to stabilize will find themselves too far behind to catch up. It is better to start now and learn through controlled, iterative experimentation.

The very governance bodies created to foster innovation, like AI councils, frequently stifle growth. As projects move from pilot to scale, these groups can become bottlenecks, multiplying reviews and killing momentum because they were designed for permission to start, not permission to grow.

Companies fail when they frame AI scaling as a technical challenge and delegate it to a digital team. Successful scaling depends on senior leadership making hard decisions about governance, ownership, and incentives—choices that cannot be made by lower-level teams. You can't tool your way out of a governance problem.

Previously, leaders carefully weighed the ROI of pursuing new features. With AI, building and testing ideas is so rapid that the strategic focus must shift. The greater risk is not a failed experiment, but failing to experiment at all. Organizations should measure the opportunity cost of not embracing AI-driven speed.